Tocilizumab, A Humanized Anti-IL-6R Antibody, as an Emerging Therapeutic Option for Rheumatoid Arthritis: Molecular and Cellular Mechanistic Insights
暂无分享,去创建一个
Seng-Lai Tan | K. Nishida | J. Takano | M. Hashizume | M. Mihara | K. Ohsawa | Ikuo Hasada | Akira Hanasaki | I. Ito